CEA, a widely used tumor marker for examination and prediction in many cancers [23] and CYFRA 21-1, an excellent tumor marker in lung cancer [24, 25], were found upregulated in breast cancer patients in several studies [26–30]. This evidence concerns the gene CEACAM5 and breast cancer.